Results 141 to 150 of about 4,329 (161)
Some of the next articles are maybe not open access.
Targeting FPR1 to prevent doxorubicin-induced cardiomyopathy
European Heart Journal SupplementsAbstract Background/Introduction Doxorubicin (DOX) is effective against cancer but can cause cardiotoxicity and immunosuppression, reducing its utility. Formyl peptide receptor-1 (FPR1) is essential for DOX-induced immunologic activation; however, a prevalent FPR1 variant (rs867228) diminishes this ...
L Schirone +6 more
openaire +1 more source
FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition
Current Medical SciencePremature rupture of membranes (PROM) is a common pregnancy disorder that is closely associated with structural weakening of fetal membranes. Studies have found that formyl peptide receptor 1 (FPR1) activates inflammatory pathways and amniotic epithelialmesenchymal transition (EMT), stimulates collagen degradation, and leads to membrane weakening and ...
Xiao-Mei, Huang +4 more
openaire +2 more sources
Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord
Frontiers in Cell and Developmental Biology, 2022Si-Pin Zhu +2 more
exaly
Synthesis and evaluation of FPR1 inhibitors as a novel treatment for cancers [1331]
2021Aghamohammadi, Amin +6 more
openaire +1 more source

